Jonathan Van Ness is getting candid about his weight loss journey. In a vulnerable new video posted to TikTok this week, the ...

Jonathan Van Ness is taking weight-loss medication to help him deal with a binge-eating disorder that, he says, caused him to ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

The evolution of AI, more limited-time product offerings and GLP-1 use for weight loss are among the issues expected to play ...

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

The New Year is a time of reflection and change for many Americans, who start each January with a clean slate and goals for the next 12 months.Many resolutions ...

Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...

Medicare drug plans can now cover Eli Lilly & Co.'s obesity drug Zepbound as a treatment for obstructive sleep apnea, news that's expected to prove a big boost for the drug company.

Jonathan Van Ness is taking weight-loss medication to help him deal with a binge-eating disorder that, he says, caused him to ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Diet food brands have been hit in recent years, but now GLP-1 drugs like Ozempic are hitting the market, will this spell the ...

Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today revealed new ...